Medtronic's latest regulatory wins further support its fast-growing arrhythmia-treating cardiac ablation business.

The regulatory authorizations come as Medtronic looks to differentiate itself in the fast-growing pulsed field ablation ...

After Medtronic's Sphere-9 catheter is threaded through the veins to reach the heart, it automatically begins transmitting information to the connected navigation system to build electro-anatomical ...

Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced regulatory milestones for software used with two cardiac ablation platforms. This includes U.S. Food and Drug ...

The new regulatory approvals expand Medtronic’s mapping and tissue-proximity capabilities for cardiac ablation.

As Boston Scientific, Medtronic, Abbott, and J&J battle for PFA market share, Pulse Biosciences could rewrite the competitive ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved a mapping and dual-energy catheter ablation system for treatment of persistent AF. The system ...

Boost ROI through pulsed field ablation, mapping systems, outpatient care and emerging markets, supported by R&D, partnerships and strong clinical evidenceDublin, Oct. 05, 2026 (GLOBE NEWSWIRE) -- ...

(RTTNews) - Boston Scientific Corp. (BSX) said it has received U.S. Food and Drug Administration approval for the navigation-enabled FARAWAVE NAV Ablation Catheter for the treatment of paroxysmal ...

Sphere-9 all-in-one mapping and ablation, large-tip focal, dual energy catheter first to be CE Marked for ventricular ablation New indication marks important milestone for ventricular arrhythmia ...

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced FDA clearance of its EnSite Precision™ cardiac mapping system and Advisor™ FL ...